不同类型抗抑郁药对生物氨基载体的作用的结构基础
Hui Wang1, April Goehring, Kevin H Wang
1Vollum Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, USA.
Nature
|October 15, 2013
概括
研究人员设计了一种细菌转运器,模仿人类生物氨基转运器 (BAT),使SSRI和SNRIs等抗抑郁药的结构研究成为可能. 这揭示了这些关键药物的共同约束原则.
科学领域:
- 结构生物学是结构生物学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 生物氨基载体 (BAT) 调节神经递质,是抗抑郁药物 (SSRI,SNRI,TCA) 的点.
- 很难从结构上研究真核生物的BAT,这限制了对抗抑郁剂机制的理解.
- 细菌同类 LeuT 提供了一个结构模型,但缺乏人类的BAT药理学.
研究的目的:
- 设计一种具有与人类BAT相似的药理学的细菌载体 (LeuT).
- 阐明抗抑郁药结合和抑制的结构机制.
- 定义管理SSRI,SNRI和TCA对BAT的行动的共同原则.
主要方法:
- 通过突变主要结合口袋附近的残留物来制造 LeuBAT 的 LeuT 传送器.
- 描述LeuBAT与各种抗抑郁药的结合亲和力,包括塞特拉林.
- 确定LeuBAT的12个晶体结构与四种类型的抗抑郁药物复合.
主要成果:
- 改造的LeuBAT突变体对SSRI,SNRI和TCA具有高亲和力结合,模仿人类BAT药理学.
- 晶体结构显示,各种抗抑郁药的结合方式类似,跨越跨膜螺旋体3并在特定螺旋体之间.
- 抗抑郁药物将LeuBAT锁定在面向外的开放形状中,与和离子结合.
结论:
- 工程 LeuBAT 成功回顾了人类的BAT药理学,为结构研究提供了一个可行的模型.
- 共同的结构原则规定了化学上不同的抗抑郁药与BAT的结合.
- 这些发现提升了我们对SSRI,SNRI和TCA在分子水平上如何起作用的理解.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
01:25Antidepressant Drugs: Overview
2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.9K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.9K
01:26Neurochemical Transmission: Sites of Drug Action
3.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K
01:25Adrenergic Agonists: Indirect-Acting Agents
2.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.8K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.4K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.4K